ArticlePDF Available

Comparison of Two Automated Immunohistochemical Procedures for the Diagnosis of Scrapie in Domestic Sheep and Chronic Wasting Disease in North American White-Tailed Deer ( Odocoileus Virginianus ) and Mule Deer ( Odocoileus Hemionus )

Authors:

Abstract and Figures

Two commercially available automated immunohistochemistry platforms, Ventana NexES and DakoCytomation Autostainer Universal Staining System, were compared for diagnosing sheep scrapie and cervid chronic wasting disease. Both automated platforms used the same antiprion protein monoclonal primary antibodies, but different platform-specific linker and amplification reagents and procedures. Duplicate sections of brainstem (at the level of the obex) and lymphoid tissue (retropharyngeal lymph node or tonsil) from the same tissue block were immunostained for the comparison. Examination of 1,020 tissues from 796 sheep revealed 100% concordance of results between the Ventana NexES and DakoCytomation platforms for diagnosing sheep scrapie from lymphoid tissue (103/103 positive; 405/405 negative) and brainstem (120/120 positive; 392/392 negative). Similarly, examination of 1,008 tissues from 504 white-tailed deer revealed 100% concordance between the Ventana NexES and DakoCytomation platforms for diagnosing chronic wasting disease from lymphoid tissue (104/104 positive; 400/400 negative) and brainstem (104/104 positive; 400/400 negative). Examination of 1,152 tissues from 482 mule deer revealed a concordance of 98.6% in lymphoid tissue and 99.9% in brainstem between the Ventana NexES and DakoCytomation platforms for diagnosing chronic wasting disease. The results indicate equivalence or near equivalence between the DakoCytomation and Ventana NexES autostainer platforms for identification of the disease-associated prion protein (PrPd)-positive and PrPd-negative brain and lymphoid tissues in sheep, white-tailed deer, and mule deer.
Content may be subject to copyright.
http://vdi.sagepub.com/
Investigation
Journal of Veterinary Diagnostic
http://vdi.sagepub.com/content/18/2/147
The online version of this article can be found at:
DOI: 10.1177/104063870601800202
2006 18: 147J VET Diagn Invest
Hall
T. V. Baszler, M. Kiupel, E. S. Williams, deceased, B. V. Thomsen, T. Gidlewski, D. L. Montgomery, K. I. O'Rourke and S. M.
)Odocoileus Hemionus) and Mule Deer (Virginianus OdocoileusDomestic Sheep and Chronic Wasting Disease in North American White-Tailed Deer (
Comparison of Two Automated Immunohistochemical Procedures for the Diagnosis of Scrapie in
Published by:
http://www.sagepublications.com
On behalf of:
Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.
can be found at:Journal of Veterinary Diagnostic InvestigationAdditional services and information for
http://vdi.sagepub.com/cgi/alertsEmail Alerts:
http://vdi.sagepub.com/subscriptionsSubscriptions:
http://www.sagepub.com/journalsReprints.navReprints:
http://www.sagepub.com/journalsPermissions.navPermissions:
What is This?
- Mar 1, 2006Version of Record >>
by guest on May 29, 2012vdi.sagepub.comDownloaded from
Comparison of two automated immunohistochemical procedures for the
diagnosis of scrapie in domestic sheep and chronic wasting disease in
North American white-tailed deer (Odocoileus virginianus) and mule
deer (Odocoileus hemionus)
T. V. Baszler,
1
M. Kiupel, E. S. Williams, B. V. Thomsen, T. Gidlewski, D. L. Montgomery,
K. I. O’Rourke, S. M. Hall
Abstract. Two commercially available automated immunohistochemistry platforms, Ventana NexES and
DakoCytomation Autostainer Universal Staining System, were compared for diagnosing sheep scrapie and
cervid chronic wasting disease. Both automated platforms used the same antiprion protein monoclonal
primary antibodies, but different platform-specific linker and amplification reagents and procedures.
Duplicate sections of brainstem (at the level of the obex) and lymphoid tissue (retropharyngeal lymph node or
tonsil) from the same tissue block were immunostained for the comparison. Examination of 1,020 tissues from
796 sheep revealed 100%concordance of results between the Ventana NexES and DakoCytomation platforms
for diagnosing sheep scrapie from lymphoid tissue (103/103 positive; 405/405 negative) and brainstem (120/120
positive; 392/392 negative). Similarly, examination of 1,008 tissues from 504 white-tailed deer revealed 100%
concordance between the Ventana NexES and DakoCytomation platforms for diagnosing chronic wasting
disease from lymphoid tissue (104/104 positive; 400/400 negative) and brainstem (104/104 positive; 400/400
negative). Examination of 1,152 tissues from 482 mule deer revealed a concordance of 98.6%in lymphoid
tissue and 99.9%in brainstem between the Ventana NexES and DakoCytomation platforms for diagnosing
chronic wasting disease. The results indicate equivalence or near equivalence between the DakoCytomation
and Ventana NexES autostainer platforms for identification of the disease-associated prion protein (PrP
d
)-
positive and PrP
d
-negative brain and lymphoid tissues in sheep, white-tailed deer, and mule deer.
Key words: Scrapie; chronic wasting disease; prion; immunohistochemistry.
Introduction
Sheep scrapie and cervid chronic wasting disease
(CWD) are prion diseases of animals, transmissible
spongiform encephalopathies (TSEs), characterized
by spongiform lesions in the brain and the accumu-
lation of an abnormal isoform of host-encoded prion
protein (PrP).
9,20
The accurate diagnosis of TSEs
relies on a combination of clinical signs of disease,
microscopic examination of the brain, and demon-
stration of the insoluble, protease-resistant, disease-
associated form of host prion protein (PrP
d
). Dem-
onstrating the accumulation of PrP
d
in affected
animals has become routine for confirmatory di-
agnosis and surveillance of animal TSEs, mainly
because disease can exist in the absence of either
clinical signs of disease or spongiform lesions,
2,5
and
detecting PrP
d
in lymphoid tissues can provide
accurate antemortem diagnosis of scrapie and CWD
during preclinical disease.
2,10,13,19
Methods for PrP
d
detection include immunohistochemical (IHC) analy-
sis, immunoblotting, and enzyme-linked immunosor-
bent assay (ELISA).
1,3,7
In most diagnostic laboratory
settings, IHC analysis has advantages over immuno-
blotting or ELISA because: 1) sampling methods are
routine for histologic examination (formalin-fixed
tissue), 2) histologic lesions can be spatially correlated
with PrP
d
accumulation,
9,16
3) the distribution pattern
of PrP
d
can be identified (disease phenotype),
4,15,17
4) depending on specific procedures, IHC analysis
may be more sensitive than immunoblotting,
6
and
From the Washington Animal Disease Diagnostic Laboratory
and Department of Veterinary Microbiology and Pathology,
College of Veterinary Medicine, Washington State University,
Pullman, WA (Baszler); and the Department of Veterinary
Pathobiology and Diagnostic Investigation, College of Veterinary
Medicine, Michigan State University, East Lansing, MI (Kiupel);
Department of Veterinary Sciences, College of Agriculture,
University of Wyoming, Laramie, WY (Williams); Texas Veter-
inary Medical Diagnostic Laboratory, Amarillo, TX (Montgom-
ery); National Veterinary Services Laboratories, US Department
of Agriculture, Animal and Plant Health Inspection Service,
Ames, IA (Gidlewski, Hall, Thomsen); and Agricultural Research
Service, US Department of Agriculture, Animal Disease Research
Unit, Pullman, WA (O’Rourke). Current address (Montgomery):
Department of Veterinary Sciences, College of Agriculture,
University of Wyoming, Laramie, WY. E. S. Williams is deceased.
1
Corresponding Author: Tim Baszler, Washington Animal
Disease Diagnostic Laboratory, Washington State University, PO
Box 2037 College Station, Pullman, WA 99165-2037l; e-mail:
baszlert@vetmed.wsu.edu
J Vet Diagn Invest 18:147–155 (2006)
147
by guest on May 29, 2012vdi.sagepub.comDownloaded from
5) automated IHC equipment and procedures are
readily available, fast, and simple.
Several manual and automated immunohistochem-
ical methods have been successfully applied to detect
PrP
d
for the diagnosis of sheep scrapie and cervid
CWD. Most techniques include steps to differentiate
PrP
d
from normal prion protein in host cells (PrP
C
),
4
epitope unmasking (usually by use of heat-induced
antigen retrieval),
8,15
and use of antibodies identifying
conserved PrP epitopes.
10,11,14
Scrapie testing and
CWD IHC analysis carried out by the Veterinary
Services of the United States Department of Agricul-
ture (USDA), and Animal and Plant Health In-
spection Service (APHIS) or its contract laboratories
is largely performed by use of the Ventana NexES
a
autostainer with proprietary immunostaining re-
agents. Results of a recent survey by the American
Association of Veterinary Laboratory Diagnosticians
indicated that many diagnostic laboratories have
proprietary automated immunostainers other than
the Ventana NexES; the DakoCytomation Autostain-
er Universal Staining System
b
was the most common
of those.
12
Because different IHC reagents and
procedures can affect the outcome of immunoreac-
tivity, equivalency testing was carried out, using the
same previously validated anti-PrP monoclonal anti-
bodies, between the Ventana NexES platform and the
DakoCytomation Autostainer Universal Staining
System for diagnosing sheep scrapie and cervid
CWD. Testing of brain and lymphoid tissues from
1,300 sheep and white-tailed deer revealed near 100%
concordance between the 2 automated immunostain-
ing platforms. Equivalency between the platforms
was slightly less in 500 mule deer tested for CWD.
Materials and methods
Animal tissues
Scrapie. Sheep of the study originated from privately
owned flocks located in 30 states representing all major
geographic regions of the United States. The sheep were
identified for the National Scrapie Eradication Program
because they were index scrapie cases (based on presence of
clinical neurologic disease and pathologic changes),
positive flock depopulations, trace-backs from positive
flocks, or slaughter surveillance. Sheep age ranged from 1
to 9 years. Breed identifications included Suffolk,
Hampshire, cross-breed, white face, black face, and
mottled face. A total of 1,020 brain or lymphoid tissues
were obtained from 796 sheep (Table 1). Lymphoid tissues
collected and examined (508 samples) included either tonsil
or retropharyngeal lymph node. Brain samples collected
and examined for the purposes of the study (512 samples)
included the brainstem at the level of the obex (containing
the dorsal motor nucleus of the vagus nerve). The lymphoid
and brain sample sets contained good- and poor-quality
(autolyzed or frozen then thawed) tissue specimens.
Ventana NexES
a
immunostaining was performed at the
National Veterinary Services Laboratories in Ames, IA and
USDA, Animal Disease Research Unit in Pullman, WA.
DakoCytomation
b
immunostaining was performed at the
Washington Animal Disease Diagnostic Laboratory at
Washington State University.
Chronic wasting disease. Tissues for CWD testing were
obtained from captive and free-ranging cervids (white-
tailed deer, and mule deer). Samples from free-ranging
cervids were obtained during hunter-kill CWD surveillance
programs in Wisconsin, Michigan, Nebraska, Wyoming,
and Colorado. Samples from captive cervids were obtained
from privately owned cervid farms as part of CWD
surveillance programs. A total of 2,160 brain or lymphoid
tissues were obtained from 986 cervids. Lymphoid tissues
collected and examined (1,174 samples) included either
tonsil or retropharyngeal lymph node. Brain collected and
examined for the purposes of the study (986 samples)
included the brainstem at the level of the obex (containing
the dorsal motor nucleus of the vagus nerve). The lymphoid
and brain sample sets contained good- and poor-quality
(autolyzed or frozen then thawed) tissue specimens.
Ventana NexES
a
immunostaining was performed at the
National Veterinary Services Laboratories in Ames, IA and
the USDA Animal Disease Research Unit in Pullman, WA.
DakoCytomation
b
immunostaining for white-tailed deer
and mule deer was performed at the Department of
Veterinary Pathobiology and Diagnostic Investigation at
Michigan State University, and at the Department of
Veterinary Sciences, University of Wyoming respectively.
Immunohistochemical methods
DakoCytomation autostainer universal staining system.
Pretreatment prior to IHC analyis for PrP
d
was performed
using heat-induced antigen retrieval and formic acid as
described.
10,15
Prior to paraffin embedding, lymphoid
tissue was placed en bloc in 96%formic acid
for 60 minutes, rinsed in distilled water, and returned
to neutral-buffered 10%formalin. Sections were
deparaffinized in xylene and graded ethanols, incubated
5 minutes with 96%formic acid, and rinsed in Tris-
buffered saline (TBS; 0.05 M Tris-HCl, 0.15 M NaCl,
pH 7.6) to neutralize acidity. Heat-induced antigen
retrieval consisted of heating sections to 121uCfor
20 minutes at 15 to 20 pounds per square inch in
modified citrate buffer (Target Retrieval Solution,
pH 6.1
b
) using either a standard tabletop autoclave or
commercially available decloaking device.
c
Table 1. Number of animals and tissues tested for scrapie or
chronic wasting disease (CWD) by immunohistochemistry using
the Ventana NexES Autostainer System and the DakoCytomation
Autostainer Universal Staining System.
Sheep White-tailed deer Mule deer
No. of animals tested 796 504 482
Lymphoid tissue 508 504 670
Brain 512 504 482
Total tissues tested 1020 1008 1152
148 Baszler et al.
by guest on May 29, 2012vdi.sagepub.comDownloaded from
After antigen retrieval, all incubations were performed at
room temperature. Blocking steps included incubation for
15 minutes with 3%H
2
O
2
in methanol to block endoge-
nous peroxidase, and in Serum-free Protein Block
b
for
5 minutes. Critical immunostaining steps associated with
the autostainer included incubation of sections with anti-
PrP primary antibody, biotinylated linker antibody, de-
tection reagent, and chromogen, interceded by washes with
IHC buffer (TBS containing 0.2%Tween 20
b
). Anti-PrP
primary antibodies consisted of F89.160.1.5
d
(F89), a mono-
clonal antibody to ruminant PrP targeting a conserved
epitope at residues 142–145 and validated for diagnosis of
scrapie,
10,11
and F99.97.6.1
d
(F99), a monoclonal antibody
to ruminant PrP targeting a conserved epitope at residues
200–225 and validated for diagnosis of scrapie and
CWD.
10,14
For scrapie assays (because of rare variation
in the F89 epitope in some sheep breeds
10
), a cocktail
containing 3.4 mg each of F89 and F99/ml was incubated
on tissue sections for 10 minutes; F99 alone at concentra-
tion of 3.4 mg/ml for a 10-minute incubation was used for
CWD assays. Biotinylated goat antimouse/rabbit IgG
linker reagent,
b
horse radish perioxidase-conjugated stre-
pavidin-biotin complex detection reagent (LSAB-HRP
Tertiary Reagent
b
), and 3-amino-9-ethyl-carbazole (AEC)
chromogen
b
were incubated on sections for 10 minutes
each. After AEC incubation, sections were rinsed with
deionized water and counterstained manually with Mayer’s
hematoxylin
b
; then coverslips were mounted by use of
aqueous mounting medium, and slides were examined by
light microscopy.
Positive-control tissue, consisting of brain or lymph node
from a known scrapie-positive sheep or CWD-positive
deer, was included in each run to confirm immunoreactivity
of the appropriate pattern and intensity in lymphoid follicle
germinal centers and in the neuropil of the brain.
11,15
Negative antibody control, consisting of either Universal
negative mouse serum
b
(DakoCytomation) or an irrelevant
isotype-matched primary antibody (anti-Neospora caninum
mAb Nc-5B6-25, 3.4 mg/ml
d
) reacted with each test slide to
ensure the lack of non-specific binding by linker or signal
amplification reagents to tissue sections. Results for test
slides were classified as positive or negative for PrP
d
. Slides
classified as PrP
d
positive had immunoreactivity in a pattern
consistent with that of positive-control slides and of that in
previous publications.
10,11,17,18
Slides classified as PrP
d
negative did not have specific immunoreactivity. Only
optimal sections were classified; if a sectioning artifact such
as detached sections was seen, the sections were recut and
tested again.
Ventana NexES. Pretreatment antigen retrieval,
antiprion primary antibodies, and positive and negative
controls for Ventana NexES IHC were identical to the
aforementioned procedures used for the DakoCytomation
Autostainer.
For automated immunostaining on the Ventana NexES
platform, all incubations were performed at 37uC using the
AEC Detection System
a
according to manufacturer’s
recommendations. Critical immunostaining steps associat-
ed with the autostainer included incubation of sections with
inhibitor (to block nonspecific binding), anti-PrP primary
antibody, biotinylated linker antibody, detection reagent,
chromogen, counterstain, and bluing reagent, interceded by
washes with IHC buffer. Anti-PrP primary antibodies, F99
for CWD and F89 plus F99 for scrapie, were the same as
those used for the Dako autostainer, but antibody
concentration was 5 mg/ml. Primary antibodies were di-
luted in proprietary antibody diluent,
a
incubation time was
32 minutes, and incubation temperature was 37uC. Bioti-
nylated linker reagent (consisting of biotinylated goat
antimouse IgG,
a
detection reagent (consisting of horse
radish perioxidase-labeled strepavidin-biotin complex
a
),
Enhancer reagent,
a
and AEC chromogen
a
were each
incubated on sections for 8 minutes. Sections were counter-
stained with Gill’s hematoxylin
a
and bluing reagent,
a
then
coverslips were mounted with aqueous mounting medium.
Results for test slides were classified as positive or negative
for PrP,
a
as described previously for slides stained by the
DakoCytomation platform. Positive slides had immunore-
activity in a pattern consistent with that of positive-control
slides and previous publications.
14,15
Only optimal sections
were classified; if sectioning artifact such as de-attached
sections was seen, the sections were recut and tested again.
Immunohistochemical comparative analysis. Scrapie and
CWD IHC testing of all samples was initially completed
using the Ventana NexES, the standard protocol used at
the National Veterinary Services Laboratories (NVSL) by 3
of the authors (BVT, TG, SMH). A random subset of
negative and positive samples (glass slides or paraffin
blocks) of brain and lymphoid tissue from sheep, white-
tailed deer, and mule deer (Table 1) were sent to authors at
participating diagnostic laboratories (Michigan State
University [MK], Washington State University [TVB],
and University of Wyoming [ESW] for subsequent
equivalency testing using the DakoCytomation
Autostainer Universal Staining System
b
). The
participating laboratories were blinded to the disease
status of the tissue specimens and used identical
immunostaining procedures (as described previously) for
scrapie and CWD testing with the DakoCytomation
Autostainer Universal Staining System.
b
Results of scrapie and CWD testing using the DakoCy-
tomation Autostainer Universal Staining System,
b
were
forwarded to the authors at USDA-NVSL in Ames, IA
(BVT, TG, SMH) or USDA-ARS-ARU in Pullman, WA
(KIO) for comparison of test results with those of the
Ventana NexES.
a
Discordant results were retested using
a ‘‘sandwich’’ technique to verify or resolve differences. The
sandwich technique consists of immunostaining 3 consec-
utive serial sections from the paraffin blocks of the
specimens of interest. The first and third sections were
immunostained using Ventana NexES, and the second
(sandwich) section was immunostained using the DakoCy-
tomation Autostainer. The sandwich technique was neces-
sary to avoid false discordant results due to sectioning
artifact between initial testing with the Ventana NexES and
subsequent testing with the DakoCytomation Autostainer,
which occurred months later and after paraffin blocks were
sealed, requiring ‘‘refacing’’ of the paraffin blocks. Indeed,
it is possible that sectioning through a small immunoreac-
tive focus in the obex or lymph node of a weakly positive
Comparing IHC methods for scrapie and CWD diagnosis 149
by guest on May 29, 2012vdi.sagepub.comDownloaded from
Figure 1. Retropharyngeal lymph node; sheep No. 1. Minimal multifocal granular immunoreactivity with anti-prion monoclonal
antibody (MAb) cocktail in cells of the germinal center (arrow). Ventana NexES IHC system. 3-Amino-9-ethyl-carbazole (AEC)
chromogen (red). Gill’s hematoxylin counterstain. Bar 590 mm.
Figure 2. Retropharyngeal lymph node; sheep No. 1. Minimal multifocal granular immunoreactivity with anti-prion MAb
cocktail in cells of the same serially sectioned germinal center as that in Figure 1 (arrow). DakoCytomation IHC system. AEC
150 Baszler et al.
by guest on May 29, 2012vdi.sagepub.comDownloaded from
sample could be interpreted as positive results on initial
testing and negative results on later testing. After initial
testing and retesting of discordant samples, comparisons of
results were tabulated as percentage concordance or
percentage discordance between the immunostaining plat-
forms for all species tested.
A random subset of 104 CWD-positive lymph nodes and
84 CWD-positive brains from white-tailed deer were
numerically classified to estimate semi-quantitative immu-
nostaining differences between the Ventana and DakoCy-
tomation platforms. The examiner (TG) was blinded to the
status of each slide. Because the number of total follicles
per section varied much between individual animals
examined, lymph nodes were classified semi-quantitatively
as: 1) minimal immunoreactivity in only a few follicles; 2)
obvious immunoreactivity, but only in a few follicles; 3)
obvious immunoreactivity in a moderate number of
follicles; 4) obvious and sometimes intense immunoreactiv-
ity in many follicles; and 5) intense immunoreactivity in
nearly all follicles. Brainstems were classified as de-
scribed,
15
namely: 1) partial immunoreactivity in the dorsal
motor nucleus of the vagus nerve; 2) total immunoreactiv-
ity of the dorsal motor nucleus of the vagus nerve; 3)
immunoreactivity extending from the dorsal motor nucleus
of the vagus nerve into the immediately adjacent neuropil;
4) moderate immunoreactivity throughout entire brainstem
section; and 5) intense immunoreactivity throughout entire
brainstem section.
Results
Sheep scrapie
A total of 1,020 tissues from 796 sheep were
examined by use of prion IHC analysis with the
Ventana NexES and DakoCytomation immunostain-
ing platforms (Table 1). Of the 508 lymphoid tissues
examined (tonsil or retropharyngeal lymph node), 103
were IHC positive and 405 were IHC negative by
both the Ventana NexES and DakoCytomation
platforms (Table 2). Of the 512 brainstems (obex)
examined, 120 were IHC positive and 392 were IHC
negative by both the Ventana NexES and DakoCy-
tomation platforms (Table 2). Initial examination
identified 5 discordant samples (4 brainstem and 1
lymph node), which on re-testing using the aforemen-
tioned serial section sandwich technique, indicated
concordant results between the 2 platforms. All
samples initially discordant were tissues that had
weak, focal immunoreactivity on initial testing using
the Ventana NexES platform and were IHC negative
Table 2. Comparison of scrapie and CWD immunohisto-
chemistry results using the Ventana NexES Autostainer System
and the DakoCytomation Autostainer Universal Staining System.
Animal Tissue (status) Ventana NexES DakoCytomation
Sheep Lymphoid
(positive)*
103 103
Lymphoid
(negative){
405 405
Brain (positive){120 120
Brain (negative)1392 392
White-tailed
deer
Lymphoid
(positive)*
104 104
Lymphoid
(negative){
400 400
Brain (positive){104 104
Brain (negative)1400 400
Mule deer Lymphoid
(positive)*
171 167
Lymphoid
(negative){
499 503
Brain (positive){102 101
Brain (negative)1380 381
* Lymphoid positive: PrPSc immunoreactivity in at least 1
germinal center.
{Lymphoid negative: no PrPSc immunoreactivity in any
germinal center (at least 10 present in sample).
{Brain positive: PrPSc immunoreactivity at least in dorsal
motor nucleus of the vagus nerve.
1Brain negative: no PrPSc immunoreactivity (dorsal motor
nucleus of vagus nerve present in sample).
r
chromogen (red). Mayer’s hematoxylin counterstain. Bar 590 mm.
Figure 3. Retropharyngeal lymph node; sheep No. 2. Moderate asymmetric granular immunoreactivity with anti-prion MAb
cocktail in cells of the germinal center. Ventana NexES IHC system. AEC chromogen (red). Gills’s hematoxylin counterstain. Bar 5
90 mm.
Figure 4. Retropharyngeal lymph node; sheep No. 2. Moderate asymmetric granular immunoreactivity with antiprion MAb
cocktail in cells of the same serially sectioned germinal center as that in Figure 3. DakoCytomation IHC system. AEC chromogen (red).
Mayer’s hematoxylin counterstain. Bar 590 mm.
Figure 5. Brainstem (obex); sheep No. 3. Immunoreactivity with anti prion MAb cocktail in the dorsal motor nucleus of the vagus
nerve (oval). Ventana NexES IHC system. AEC chromogen (red). Gill’s hematoxylin counterstain. Bar 5800 mm.
Figure 6. Brainstem (obex); sheep No. 3. Immunoreactivity with antiprion MAb cocktail in a serial section of the same dorsal
motor nucleus of the vagus nerve as that in Figure 5 (oval). DakoCytomation IHC system. AEC chromogen (red). Mayer’s hematoxylin
counterstain. Bar 5800 mm.
Figure 7. Brainstem (obex); sheep No. 3. Higher magnification of Figure 5. Ventana NexES IHC system. AEC chromogen (red).
Gill’s hematoxylin counterstain. Bar 5160 mm.
Figure 8. Brainstem (obex); sheep No. 3. Higher magnification of Figure 6. DakoCytomation IHC system. AEC chromogen (red).
Mayer’s hematoxylin counterstain. Bar 5160 mm.
Comparing IHC methods for scrapie and CWD diagnosis 151
by guest on May 29, 2012vdi.sagepub.comDownloaded from
Figure 9. Retropharyngeal lymph node; white-tailed deer No. 1. Moderate multifocal granular immunoreactivity with antiprion
MAb in cells of the germinal center. Ventana NexES IHC system. AEC chromogen (red). Gill’s hematoxylin counterstain. Bar 5
110 mm.
Figure 10. Retropharyngeal lymph node; white-tailed deer No. 1. Moderate multifocal granular immunoreactivity with antiprion
MAb in cells of the same serially sectioned germinal center as that in Figure 9. DakoCytomation IHC system. AEC chromogen (red).
152 Baszler et al.
by guest on May 29, 2012vdi.sagepub.comDownloaded from
using the DakoCytomation platform, which was
performed at a later date after the paraffin blocks
were resealed. On re-testing using serial sections, the
tissues were IHC negative by use of both platforms.
Thus, there was 100%concordance between the
Ventana NexES and DakoCytomation immunostain-
ing platforms in identifying PrP
d
-positive or PrP
d
-
negative brain and lymphoid tissues in sheep.
Overall, the quality of prion immunoreactivity was
equivalent between the Ventana NexES and Dako-
Cytomation immunostaining platforms (Figs. 1–8). In
lymphoid tissue, immunoreactivity was granular and
multifocal in germinal centers, a pattern consistent
with PrP
Sc
accumulation in lymphoid tissue (Figs. 1–
4).
10,17
Use of both platforms identified weakly
positive germinal centers, although the signal in-
tensity was slightly stronger for the Ventana NexES
platform (Figs. 1, 2). In brain tissue, the signal-to-
noise ratio was slightly higher in the Ventana NexES,
compared with the DakoCytomation platform
(Figs. 5–8). However, use of both platforms yielded
an immunoreactivity pattern typical of PrP
d
in sheep
with scrapie (i.e., plaques, cellular processes, peri-
neuronal rims, and perivascular accumulations,
11,18
and both platforms identified sheep early in disease,
with PrP
d
immunoreactivity restricted to focal regions
of the dorsal motor nucleus of the vagus nerve
(Figs. 5, 6).
Chronic wasting disease in white-tailed deer
A total of 1,008 tissues from 504 white-tailed deer
were examined by use of prion IHC analysis with the
Ventana NexES and DakoCytomation immunostain-
ing platforms (Table 1). Of the 504 lymphoid tissues
examined (tonsil or retropharyngeal lymph node), 104
were IHC positive and 400 were IHC negative by
both platforms (Table 2). Of the 504 brainstems
(obex) examined, 104 were IHC positive and 400 were
IHC negative by both platforms (Table 2). Thus,
there was 100%concordance between the Ventana
NexES and DakoCytomation immunostaining plat-
forms in identifying PrP
d
-positive or PrP
d
-negative
brain and lymphoid tissues in white-tailed deer.
There were no obvious semiquantitative differences
in immunoreactivity between the Ventana NexES and
DakoCytomation platforms using the aforemen-
tioned 1–5 numerical grading system to classify
a random subset of 104 CWD-positive lymph nodes
and 84 CWD- positive brainstems. Numbers of lymph
node specimens classified within each numerical grade
were: grade 1 513, grade 2 528, grade 3 534, grade
4529, and grade 5 50. Numbers of brainstem
samples classified within each numerical grade were:
grade 1 518, grade 2 522, grade 3 525, grade 4 5
15, and grade 5 54. The majority of brainstems
(86%; 72/84) were classified identically between the 2
immunostaining platforms. Similarly, most lymph
nodes (90%; 94/104) were classified identically be-
tween the 2 immunostaining platforms. The lymph
nodes and brainstems classified differently for in-
tensity of immunoreactivity varied by only 1 numer-
ical category (i.e., 4 vs. 5 or 1 vs. 2). Neither platform
had consistently higher scoring than the other.
Overall, the quality of prion immunoreactivity was
equivalent between the 2 immunostaining platforms
(Figs. 9–16). In lymphoid tissue, immunoreactivity
was granular and multifocal in germinal centers,
a pattern consistent with PrP
d
accumulation in
lymphoid tissue (Figs. 9–12).
14
Both platforms
identified weakly positive germinal centers, although
the signal intensity was slightly stronger for the
Ventana platform (Figs. 9, 10). In brain tissue, the
signal-to-noise ratio was slightly higher for the
Ventana, compared with the DakoCytomation plat-
form (Figs. 13–16). However, use of both platforms
yielded an immunoreactivity pattern typical of PrP
d
in
r
Mayer’s hematoxylin counterstain. Bar 5110 mm.
Figure 11. Retropharyngeal lymph node; white-tailed deer No. 2. Moderate asymmetric granular immunoreactivity with antiprion
MAb in cells of the germinal center. Ventana NexES IHC system. AEC chromogen (red). Gill’s hematoxylin counterstain. Bar 590 mm.
Figure 12. Retropharyngeal lymph node; white-tailed deer No. 2. Moderate asymmetric granular immunoreactivity with antiprion
MAb in cells of the same serially sectioned germinal center as that in Figure 11. DakoCytomation IHC system. AEC chromogen (red).
Mayer’s hematoxylin counterstain. Bar 590 mm.
Figure 13. Brainstem (obex); white-tailed deer No. 3. Immunoreactivity with antiprion MAb cocktail in the dorsolateral region of
the dorsal motor nucleus of the vagus nerve (oval). Ventana NexES IHC system. AEC chromogen (red). Gill’s hematoxylin counterstain.
Bar 5600 mm.
Figure 14. Brainstem (obex); white-tailed deer No. 3. Immunoreactivity with antiprion MAb cocktail in a serial section of the
same dorsal motor nucleus of the vagus nerve as that in Figure 13 (oval). DakoCytomation IHC system. AEC chromogen (red). Mayer’s
hematoxylin counterstain. Bar 5600 mm.
Figure 15. Brainstem (obex); white-tailed deer No. 3. Higher magnification of Figure 13. Ventana NexES IHC system. AEC
chromogen (red). Gill’s hematoxylin counterstain. Bar 5190 mm.
Figure 16. Brainstem (obex); white-tailed deer No. 3. Higher magnification of Figure 14. DakoCytomation IHC system. AEC
chromogen (red). Mayer’s hematoxylin counterstain. Bar 5190 mm.
Comparing IHC methods for scrapie and CWD diagnosis 153
by guest on May 29, 2012vdi.sagepub.comDownloaded from
deer with CWD (i.e., plaques, cellular processes,
perineuronal rims, and perivascular accumulations
(Figs. 15, 16),
11,18
and use of both platforms identified
deer early in disease, with PrP
d
immunoreactivity
restricted to the dorsal motor nucleus of the vagus
nerve (Figs. 13, 14).
There was slightly more nonspecific background
reactivity in the deer tissues tested for CWD than in
the sheep tissues tested for scrapie. Some deer tissues
stained by use of the Ventana NexES platform had
fine diffuse reactivity of the neuropil and intracyto-
plasmic reactivity of lymphocytes in lymph nodes.
Some deer tissues stained by use of the DakoCytoma-
tion platform had intraneuronal reactivity in the
brain, and in lymph nodes, accentuation of germinal
centers with orange brown reactivity was apparent.
However, the increased background visualized in
some deer tissues did not affect classification of
tissues as CWD positive or CWD negative.
Chronic wasting disease in mule deer
A total of 1,152 tissues from 482 mule deer were
examined by use of prion IHC analysis with the
Ventana NexES and DakoCytomation immunostain-
ing platforms (Table 1). Similar to tissues from white-
tailed deer tested for CWD, the quality of prion
immunoreactivity was equivalent between the 2
immunostaining platforms (data not shown). Of the
670 lymphoid tissues examined (tonsil or retrophar-
yngeal lymph node), 171 were IHC positive and 499
were IHC negative by use of the Ventana NexES
platform, and 167 were IHC positive and 503 were
IHC negative by use of the DakoCytomation
platform (Table 2), calculating to a 98.8%overall
concordance ([662/670] 3100). Of the 482 brainstems
(obex), examined, 102 were IHC positive and 380
were IHC negative by use of the Ventana NexES
platform, and 101 were IHC positive and 381 were
IHC negative by use of the DakoCytomation
platform (Table 2), calculating to a 99.6%overall
concordance ([480/482] 3100). For all of the
discordant samples, the DakoCytomation results
were repeatable in the individual testing laboratory
of one of the authors (ESW). However, due to
logistical problems retrieving archived tissue blocks,
the discordant results were not retested by both the
DakoCytomation and Ventana NexES systems using
the aforementioned sandwich technique. All discor-
dant samples were PrP
d
positive using the Ventana
NexES platform and were PrP
d
negative using the
DakoCytomation Universal platform. Thus, in total,
there was slightly less concordance between the
Ventana NexES and DakoCytomation immunostain-
ing platforms in identifying PrP
d
-positive or PrP
d
-
negative brain and lymphoid tissues in mule deer.
Discussion
Comparative testing of 2 automated immunostain-
ing platforms, Ventana NexES
a
Autostainer System
and DakoCytomation Autostainer Universal Staining
System,
b
revealed 100%concordance in correctly
classifying scrapie-positive and scrapie-negative
sheep, and CWD-positive and CWD-negative white-
tailed deer. Concordance was slightly ,100%for
mule deer with CWD. Use of both immunostaining
systems produced sections that were easily interpreted
and readily classified as PrP
d
positive or PrP
d
negative. The comparative testing was done in 5
laboratories, state and federal, carried out by
different technical personnel, and interpreted by
different pathologists at the respective institutions.
The results illustrate the reliability of either immu-
nostaining platform to detect scrapie and CWD, and
endorse the official use of both platforms in
laboratories approved for TSE testing.
The reason for the minimal discordance between
the Ventana NexES and DakoCytomation immuno-
staining platforms (1.2%for lymphoid tissue and
0.4%for brainstem) when classifying tissues as PrP
d
positive or PrP
d
negative from mule deer with
suspected CWD was not clearly evident from the
study. It is possible the Ventana NexES immuno-
staining platform was more sensitive with this subset
of tissue, perhaps due to the higher primary antibody
concentration used in the assay (5 mg/ml), compared
with that of the DakoCytomation platform (3.4 mg/
ml). However, the authors cannot differentiate with
certainty whether the Ventana NexES was more
sensitive or less specific than the DakoCytomation
platform (all the discordant samples were positive
using the Ventana NexES platform and were negative
using the DakoCytomation platform). Since the
discordant mule deer samples could not be retested
using the ‘‘sandwich’’ technique (because archived
blocks could not be retrieved), it is possible that
a small focus of immunoreactivity that was identified
using the Ventana NexES platform on initial screen-
ing was no longer present in the block when sections
were made for testing by the DakoCytomation
platform. It is possible there was no discordance at
all between the 2 systems in diagnosing CWD in the
mule deer samples tested. Finally, since all samples
were formalin fixed, it was not possible to further
verify the status of the samples in question by using
other detection methods such as Western blotting or
ELISA.
The slight qualitative differences in prion immuno-
reactivity between the Ventana NexES
a
and Dako-
Cytomation
b
autostainers could be a matter of
personal preference or due to methodologic differ-
154 Baszler et al.
by guest on May 29, 2012vdi.sagepub.comDownloaded from
ences. For example, the proprietary AEC chromogen
and hematoxylin counterstain of the Ventana NexES
platform produced a slightly magenta-red signal
against an aqua-blue counterstain, compared with
the red-brown AEC and darker blue hematoxylin of
the DakoCytomation platform. Also, the apparent
increased signal strength in the Ventana NexES
platform could have been due to the higher concen-
tration and incubation time of the primary antiprion
monoclonal antibodies (5 mg/ml for 32 minutes at
37uC), compared with those of the DakoCytomation
platform (3.4 mg/ml for 10 minutes at ambient
temperature). Regardless of these technical differ-
ences, the end result, prion immunoreactivity, did not
significantly vary sufficiently to incorrectly classify
a given tissue regarding TSE status. Furthermore, the
equal performance of the DakoCytomation and
Ventana NexES platforms in semi-quantitative grad-
ing classification, even for samples with minimal PrP
d
immunoreactivity, strengthens the conclusion that
both systems perform similarly.
Acknowledgements
The authors wish to acknowledge the excellent technical
assistance provided by technical staff at Michigan State
University Diagnostic Center for Population and Animal
Health, University of Wyoming Department of Veterinary
Science, and USDA/APHIS/NVSL, Pam Robertson at the
Washington Animal Disease Diagnostic Laboratory, and
Tom Truscott at USDA/ARS/ADRU Pullman, WA.
Sources and manufacturers
a. Ventana Medical Systems, Tucson, AZ.
b. DakyCytomation Inc., Carpinteria, CA.
c. BioCare Medical, Walnut Creek, CA.
d. VMRD Inc., Pullman, WA.
References
1. Bennion BJ, Daggett V: 2002, Protein conformation and
diagnostic tests: the prion protein. Clin Chem 48:2105–2114.
2. Bradley R: 1997, Animal prion diseases. In: Prion diseases, ed.
Collinge J, Palmer MS, pp. 89–129. Oxford University Press,
Oxford, UK.
3. Farquhar CF, Somerville RA, Ritchie LA: 1989, Post-mortem
immunodiagnosis of scrapie and bovine spongiform enceph-
alopathy. J Virol Methods 24:215–221.
4. Foster JD, Wilson M, Hunter N: 1996, Immunolocalisation of
prion protein (PrP) in the brains of sheep with scrapie. Vet
Rec 139:512–515.
5. Fraser H: 1976, The pathology of natural and experimental
scrapie. In: Slow virus diseases of animals and man, ed.
Kimberlin RH, pp. 276–305. North-Holland, Amsterdam,
The Netherlands.
6. Herrmann LM, Baszler TV, Knowles DP, Cheevers WP: 2002,
PrP(Sc) is not detected in peripheral blood leukocytes of
scrapie-infected sheep: determining the limit of sensitivity by
immunohistochemistry. Clin Diagn Lab Immunol 9:499–502.
7. Ingrosso L, Vetrugno V, Cardone F, Pocchiari M: 2002,
Molecular diagnostics of transmissible spongiform encepha-
lopathies. Trends Mol Med 8:273–280.
8. Miller J, Jenny A, Taylor W, et al.: 1994, Detection of prion
protein in formalin-fixed brain by hydrated autoclaving
immunohistochemistry for the diagnosis of scrapie in sheep.
J Vet Diag Invest 6:366–368.
9. O’Rourke KI: 2001, Ovine scrapie. New tools for control of
an old disease. Vet Clin North Am Food Anim Pract
17:283–300, vi.
10. O’Rourke KI, Baszler TV, Besser TE, et al.: 2000, Preclinical
diagnosis of scrapie by immunohistochemistry of third eyelid
lymphoid tissue. J Clin Microbiol 38:3254–3259.
11. O’Rourke KI, Baszler TV, Miller JM, et al.: 1998, Mono-
clonal antibody F89/160.1.5 defines a conserved epitope on
the ruminant prion protein. J Clin Microbiol 36:1750–1755.
12. Ramos-Vara JA, Kiupel M, Miller MA: 2005, Immunohisto-
chemical testing in veterinary diagnostic laboratories: results
of a survey of 47 laboratories. J Histotechnol 28:19–23.
13. Schreuder BE, van Keulen LJ, Vromans ME, et al.: 1998,
Tonsillar biopsy and PrPSc detection in the preclinical
diagnosis of scrapie. Vet Rec 142:564–568.
14. Spraker TR, O’Rourke KI, Balachandran A, et al.: 2002,
Validation of monoclonal antibody F99/97.6.1 for immuno-
histochemical staining of brain and tonsil in mule deer
(Odocoileus hemionus) with chronic wasting disease. J Vet
Diagn Invest 14:3–7.
15. Spraker TR, Zink RR, Cummings BA, et al.: 2002,
Distribution of protease-resistant prion protein and spongi-
form encephalopathy in free-ranging mule deer (Odocoileus
hemionus) with chronic wasting disease. Vet Pathol
39:546–556.
16. Spraker TR, Zink RR, Cummings BA, et al.: 2002,
Comparison of histological lesions and immunohistochemical
staining of proteinase-resistant prion protein in a naturally
occurring spongiform encephalopathy of free-ranging mule
deer (Odocoileus hemionus) with those of chronic wasting
disease of captive mule deer. Vet Pathol 39:110–119.
17. van Keulen LJ, Schreuder BE, Meloen RH, et al.: 1995,
Immunohistochemical detection and localization of prion
protein in brain tissue of sheep with natural scrapie. Vet
Pathol 32:299–308.
18. van Keulen LJ, Schreuder BE, Meloen RH, et al.: 1996,
Immunohistochemical detection of prion protein in lymphoid
tissues of sheep with natural scrapie. J Clin Microbiol
34:1228–1231.
19. Wild MA, Spraker TR, Sigurdson CJ, et al.: 2002, Preclinical
diagnosis of chronic wasting disease in captive mule deer
(Odocoileus hemionus) and white-tailed deer (Odocoileus
virginianus) using tonsillar biopsy. J Gen Virol 83:2629–2634.
20. Williams ES, Miller MW: 2002, Chronic wasting disease in
deer and elk in North America. Rev Sci Tech 21:305–316.
Comparing IHC methods for scrapie and CWD diagnosis 155
by guest on May 29, 2012vdi.sagepub.comDownloaded from
... Immunohistochemistry (IHC) provides a great deal of diagnostic certainty. A sample is identified as positive when immunostaining specific for disease forms of the prion protein (e.g., PrP CWD ) can be visualized in expected locations such as lymphoid follicles [3]. ...
Article
Full-text available
Chronic wasting disease (CWD) continues to spread in wild and farmed cervid populations. Early antemortem CWD testing of farmed cervids is of considerable interest to producers and regulatory agencies as a tool to combat this spread. The tissues accessible for antemortem sampling are limited and include biopsy of the tonsil and recto-anal mucosa-associated lymphoid tissue (RAMALT). The sensitivity to detect CWD by immunohistochemistry (IHC)-the regulatory gold standard-using biopsy samples of RAMALT from naturally infected white-tailed deer (WTD) has been determined by several studies. However, similar information is lacking for tonsil biopsy. In this study, two-bite tonsil biopsies from 79 naturally infected farmed WTD were used to determine the diagnostic sensitivity of tonsil IHC compared to the official CWD status based on results from the medial retropharyngeal lymph nodes and obex. IHC detection of CWD by tonsil biopsy was compared to the result and follicle metrics from the contralateral whole tonsil. The sensitivity of two-bite tonsil biopsy for detecting CWD by IHC was 72% overall. When the stage of infection was considered, the sensitivity was 92% for deer in late preclinical infection but only 55% for early preclinical infection. For deer with early preclinical infection, the sensitivity for deer homozygous for the prion protein gene (PRNP) coding for glycine at codon 96 (GG) was 66% but only 30% when heterozygous for the serine substitution (GS). The results indicate that the sensitivity of two-bite tonsil biopsy in WTD, and consequently its potential utility as an antemortem diagnostic, is limited during early infection, especially in WTD heterozygous for the serine substitution at PRNP codon 96.
... These tests, based on detection of PrP Sc by ELISA were initially approved just for post-mortem analysis of brain samples [150], but the numerous reports on ante-mortem detection of prions in lymphoreticular system of sheep and cervids [131,[151][152][153][154][155] prompted their use on lymphoid tissue as well as on brain samples [156]. Lymphoid tissues of choice, due to accessibility and ease of sampling and their association with the gastrointestinal track, are retropharyngeal lymph nodes and tonsils [151,157,158]. However, in sheep [159][160][161] and mainly in deer, another lymphoid tissue or its associated mucosa has been also widely used, namely the RAMALT [149,162]. ...
Article
Full-text available
Transmissible spongiform encephalopathies or prion diseases are rapidly progressive neurodegenerative diseases, the clinical manifestation of which can resemble other promptly evolving neurological maladies. Therefore, the unequivocal ante-mortem diagnosis is highly challenging and was only possible by histopathological and immunohistochemical analysis of the brain at necropsy. Although surrogate biomarkers of neurological damage have become invaluable to complement clinical data and provide more accurate diagnostics at early stages, other neurodegenerative diseases show similar alterations hindering the differential diagnosis. To solve that, the detection of the pathognomonic biomarker of disease, PrPSc, the aberrantly folded isoform of the prion protein, could be used. However, the amounts in easily accessible tissues or body fluids at pre-clinical or early clinical stages are extremely low for the standard detection methods. The solution comes from the recent development of in vitro prion propagation techniques, such as Protein Misfolding Cyclic Amplification (PMCA) and Real Time-Quaking Induced Conversion (RT-QuIC), which have been already applied to detect minute amounts of PrPSc in different matrixes and make early diagnosis of prion diseases feasible in a near future. Herein, the most relevant tissues and body fluids in which PrPSc has been detected in animals and humans are being reviewed, especially those in which cell-free prion propagation systems have been used with diagnostic purposes.
... 96GS,96SS Wild et al. (2002),Hibler et al. (2003),Baszler et al. (2006),Wolfe et al. (2007),Keane et al. (2008aKeane et al. ( ,b, 2009,Greenlee et al. (2011) (b) ,Thomsen et al. (2012),Henderson et al. ...
Article
Full-text available
Abstract The European Commission asked EFSA for a scientific opinion on chronic wasting disease in two parts. Part one, on surveillance, animal health risk‐based measures and public health risks, was published in January 2017. This opinion (part two) addresses the remaining Terms of Reference, namely, ‘are the conclusions and recommendations in the EFSA opinion of June 2004 on diagnostic methods for chronic wasting disease still valid? If not, an update should be provided’, and ‘update the conclusions of the 2010 EFSA opinion on the results of the European Union survey on chronic wasting disease in cervids, as regards its occurrence in the cervid population in the European Union’. Data on the performance of authorised rapid tests in North America are not comprehensive, and are more limited than those available for the tests approved for statutory transmissible spongiform encephalopathies surveillance applications in cattle and sheep. There are no data directly comparing available rapid test performances in cervids. The experience in Norway shows that the Bio‐Rad TeSeE™ SAP test, immunohistochemistry and western blotting have detected reindeer, moose and red deer cases. It was shown that testing both brainstem and lymphoid tissue from each animal increases the surveillance sensitivity. Shortcomings in the previous EU survey limited the reliability of inferences that could be made about the potential disease occurrence in Europe. Subsequently, testing activity in Europe was low, until the detection of the disease in Norway, triggering substantial testing efforts in that country. Available data neither support nor refute the conclusion that chronic wasting disease does not occur widely in the EU and do not preclude the possibility that the disease was present in Europe before the survey was conducted. It appears plausible that chronic wasting disease could have become established in Norway more than a decade ago.
... Immunohistochemical analysis is a mainstay of scrapie testing in the United States. 5 Prior to determining the impact of allele effects on detection of PrP Sc by IHC with in-house single antibody scrapie IHC protocols for F99 and F89, antibody concentrations were titrated and formic acid treatments (0 vs. 3 vs. 5 min on slide) were compared (data not shown). Efforts were made to optimize for strong labeling of positive aggregates in the dorsal motor nucleus of the vagus nerve and clean labeling, which lacked pink hues. ...
Article
Full-text available
Diagnostic analyses often employ single antibody systems but are potentially limited by epitope sequence variation. United States regulatory testing for scrapie primarily uses antibody F99/97.6.1 for immunohistochemistry (IHC) of the prion protein associated with scrapie (PrP(Sc)). Whereas the epitope bound by F99/97.6.1 is highly conserved in sheep, a polymorphism in caprine PRNP results in a glutamine to lysine change at codon 222 and affects PrP detection. This study evaluated the performance of immunoassays (Western blot and IHC) in the presence of PRNP polymorphisms observed in U.S. goat populations. Effects of naturally occurring caprine prion protein alterations at codons 142, 143, 146, 154, or 222 were first evaluated using bacterially expressed recombinant normal cellular prion protein (rec-PrP(C)) and commercially available antibodies (F99/97.6.1, F89/160.1.5, L42, and SAF84). Detection of rec-PrP(C) using F89/160.1.5 was reduced by alterations at 142 and 143; this was also observed in brain PrP(C) from goats expressing these PRNP variants. Effect of allelic variation at 222 was confirmed by Western blot with F99/97.6.1. No differences were observed with L42 or SAF84. IHC of brain demonstrated reduced signal with F89/160.1.5 in animals heterozygous at 143. Decreasing F89/160.1.5 titers were used to demonstrate the impact of PrP(Sc) immunolabeling in preclinical goats and as a surrogate for F99/97.6.1 detection in 222 variants. In the absence of epitope-relevant knowledge of individual goat PRNP, a multi-antibody approach or an antibody that binds an invariant site may provide a more robust immunoassay of PrP(Sc) in classical scrapie, thus reducing the likelihood of false-negative results due to allelic variation. © 2015 The Author(s).
... An IHC test can be validated by comparing results among laboratories using similar techniques. 16 When possible, validation compares the IHC test sensitivity to that of the ''gold standard'' method for the antigen in question. It may also compare staining patterns and sensitivity with other antibodies targeting the same antigen. ...
Article
Once focused mainly on the characterization of neoplasms, immunohistochemistry (IHC) today is used in the investigation of a broad range of disease processes with applications in diagnosis, prognostication, therapeutic decisions to tailor treatment to an individual patient, and investigations into the pathogenesis of disease. This review addresses the technical aspects of immunohistochemistry (and, to a lesser extent, immunocytochemistry) with attention to the antigen-antibody reaction, optimal fixation techniques, tissue processing considerations, antigen retrieval methods, detection systems, selection and use of an autostainer, standardization and validation of IHC tests, preparation of proper tissue and reagent controls, tissue microarrays and other high-throughput systems, quality assurance/quality control measures, interpretation of the IHC reaction, and reporting of results. It is now more important than ever, with these sophisticated applications, to standardize the entire IHC process from tissue collection through interpretation and reporting to minimize variability among laboratories and to facilitate quantification and interlaboratory comparison of IHC results.
Chapter
In this chapter, the preclinical applications of several molecular pathology technologies in advancing drug discovery and development are discussed, including immunohistochemistry, immunofluorescence, in situ hybridization RNAScope, tissue microarrays, laser-capture microscopy, toxicogenomics, tissue biomarkers, digital pathology imaging, stereology, and microRNA analysis. Examples are provided to illustrate the utility of each specific technology for the identification, characterization, and elucidation of the pathogenetic mechanism(s) of drug-related tissue alterations.
Chapter
In many laboratories, immunohistochemistry (IHC) has become a routine supplement to the classic morphologic approach of investigational pathology. The specificity of the IHC test is largely dependent on the ability of the primary antibody to bind to epitopes on the target antigen without cross-reacting to epitopes on off-target antigens. The development of a new IHC test begins with the optimization of each of the steps in the analytical phase (phase 2) of the IHC test including: antigen retrieval, blocking nonspecific activities, and the binding and selection of primary antibody. This chapter discusses the use of some intermediate filaments (IFs) in IHC of neoplastic diseases. Cancer of unknown primary site (CUPS) includes all cancers in which the tissue or organ of origin cannot be determined by clinicopathologic analysis. Following the human oncology approach for IHC to identify CUPS, the main tumor categories are carcinoma, melanoma, leukocytic tumors (including histiocytic) and sarcoma.
Chapter
In this chapter, the preclinical applications of several molecular pathology technologies in advancing drug discovery and development are discussed, including immunohistochemistry, immunofluorescence, in situ hybridization RNAScope, tissue microarrays, laser-capture microscopy, toxicogenomics, tissue biomarkers, digital pathology imaging, stereology, and microRNA analysis. Examples are provided to illustrate the utility of each specific technology for the identification, characterization, and elucidation of the pathogenetic mechanism(s) of drug-related tissue alterations.
Article
Forty-seven veterinary diagnostic laboratories (37 in the United States, 5 in Canada, and 5 overseas) participated in a survey of immunohistochemical (IHC) testing. The survey had three sections: 1) general, 2) type of tests, and 3) laboratory practice and quality assurance/quality control. Most laboratories performed THC for both diagnostic and research purposes. The number of testslyear ranged from 20,000 (most frequent range, 1000–5000). Most respondents expected the number of IHCs to increase. More than 60% coisidered IHC at least as relevant as other ancillary tests. About half the laboratories charged a fee per IHC test; the rest included IHC costs in the histopathology fee. The fee per test ranged from less than 10 to more than 30, with 75% of laboratories charging a fee of 11–30. All laboratories used formalin-fixed, paraffin-embedded samples routinely and frozen sections or tissues fixed in other fixatives much less frequently. Forty-three percent of laboratories performed IHC both for infectious and neoplastic diseases. Prion protein, bovine viral diarrhea virus, porcine reproductive and respiratory syndrome virus, and West Nile virus were the most common infectious diseases tests. The most common tests for cell markers were cytokeratins, virnentin, and CD3. Only four laboratories (two in the United States. one in Canada, and one overseas) had IHC procedures that followed IS0 17025 standards. Standardization of a test typically included checkerboard titrations of antisera, different antigen retrieval procedures, and known-positive tissue controls. A negative serum control was included for each specimen in
Article
Two polyclonal antisera were raised in rabbits against the scrapie-associated fibril protein (PrP) prepared from sheep and mice which were terminally infected with experimental scrapie. The anti-mouse PrP serum identifies the proteins of scrapie-associated fibrils (SAF) from all the host species studied (mouse, hamster, sheep and goat) and bovine spongiform encephalopathy (BSE) fibrils from cow. The anti-sheep PrP serum displays species restricted immunoreactivity. While it identifies several PrP polypeptides from terminally affected sheep, goat and cow material, only the highest molecular weight band is recognised from hamster and there is no detection of mouse PrP. The use of these antisera in routine laboratory testing at post mortem provides a highly sensitive test for scrapie and BSE and may allow the identification of infected animals prior to the onset of clinical signs.
Article
A converted form of the normal cellular prion protein (PrP) accumulates in the brains of sheep with scrapie. We describe an immunohistochemical method for identifying scrapie-associated PrP (PrPSc) in periodate-lysine-paraformaldehyde-fixed brain tissue, which provides adequate preservation of tissue morphology. After pretreatment of tissue sections with formic acid and hydrated autoclaving, we located PrPSc in the brains of 50 sheep with natural scrapie by use of antipeptide antisera raised against ovine PrP. No PrP was seen in 20 sheep without histopathologic signs of scrapie. PrPSc that did not stain for amyloid was present in the cytoplasm and at the cell membrane of both neurons and astrocytes. Large amounts of PrPSc were seen at the cell membrane of neurons in the medulla oblongata and pons, whereas PrPSc accumulated at the cell membrane of astrocytes of the glial limitans in all brain regions. PrPSc that stained for amyloid was located in the walls of blood vessels and perivascularly in the brains of 32 (64%) of 50 sheep, mainly in the thalamus and never in the pons or medulla oblongata. No apparent topographic relationship existed between PrPSc that stained for amyloid and PrPSc accumulation associated with neurons or astrocytes. In all scrapie-affected sheep, PrPSc was present in brain regions with vacuolation, but it could also be detected in regions with minimal or no vacuolation. We conclude that the immunohistochemical detection of PrP can be an important confirmative test in scrapie diagnosis.
Article
4The diagnosis of scrapie has traditionally relied on histopatholog ic demonstration of characteristi c lesions in brain sections. In recent years, however, increasing attention has been given to the use of immunodiagnos tic methods that focus on detection of a specific protein known as the prion protein (PrP). 7 This protein, which is believed to play an essential role in the pathogenesis of scrapie, is present in normal brain as a protease-sensitive isoform (PrP-sen). In contrast, most of the PrP in scrapie brain is protease resistant (PrP-res), probably because of a posttranslational alteration affecting the conformation of normal PrP. An immunohistoch emical (IHC) method to detect PrP-res in periodate, lysine, paraformaldehyde (PLP)-fixed brains from sheep with scrapie has been described. 5 Researchers working on bovine spongiform encephalopathy have recently reported that PrP-res also can be detected in formalin-fixe d brain if tissue sections are autoclaved prior to immunostaining. 1 This novel method of antigen enhancement, termed hydrated autoclaving, was originally devised to improve the immunoreactivity of certain brain proteins. 10 Hydrated autoclaving has not been used to detect other antigens. However, antigen enhancement is believed to result from heat denaturation of the protein, and the same mechanism has been suggested as the basis for antigen retrieval methods that utilize microwave immunohistochemistry. 6 In the present report, we describe diagnosis of scrapie using hydrated autoclaving IHC on formalin-fixe d sheep brains. For comparative purposes, some brains also were tested for PrP-res by western blot assay or by IHC on PLP-fixed brain. Brain samples from 186 scrapie suspect sheep were submitted to veterinary medical colleges, state veterinary diagnostic laboratories, or the National Veterinary Services Laboratories. Additional brain samples from 10 sheep in a scrapiefree flock were used as controls. Tissue sections were cut from paraffin blocks of formalin-fixe d brain stem (usually obex or midmedulla) and mounted on positively charged
Article
The scrapie-associated form of the prion protein (PrPSc) accumulates in the brain and lymphoid tissues of sheep with scrapie. In order to assess whether detecting PrPSc in lymphoid tissue could be used as a diagnostic test for scrapie, we studied the localization and distribution of PrPSc in various lymphoid tissues collected at necropsy from 55 sheep with clinical scrapie. Samples collected from the spleen, palatine tonsil, ileum, and five different lymph nodes were immunohistochemically stained for PrPSc. PrPSc was found to be deposited in a reticular pattern in the center of both primary and secondary lymphoid follicles. In addition, granules of PrPSc were seen in the cytoplasm in macrophages associated with the lymphoid follicles. In 54 (98%) of the 55 scrapie-affected sheep, PrPSc was detected in the spleen, retropharyngeal lymph node, mesenteric lymph node, and the palatine tonsil. However, only in the palatine tonsils was PrPSc present in a consistently high percentage of the lymphoid follicles. PrP was not detected in any of the lymphoid tissues of 12 sheep that had no neurohistopathological signs of a scrapie infection. We conclude that the tonsils are the best-suited lymphoid tissue to be biopsied for the detection of PrPSc in the diagnosis of clinical scrapie in living sheep.
Article
Cheviot sheep from the Neuropathogenesis Unit flock were examined for PrP in brain sections using immunocytochemistry in order to aid scrapie diagnosis. Brains were collected from sheep which had been naturally or experimentally infected with scrapie and fixed in periodate-lysine-paraformaldehyde or in formalin. Immunolabelling was achieved using a monoclonal antibody (FH11) raised to the N-terminus of recombinant PrP protein. Several pre-treatments were studied in an effort to enhance PrP immunolabelling such as trypsin, formic acid and hydrated autoclaving. Trypsin was successful in highlighting PrP staining in formalin-fixed tissue. PrP staining was regularly observed in the dorsal vagus nucleus of the medulla oblongata and in the thalamus. Differences in the distribution and intensity of PrP immunostaining were apparent between the scrapie sources ME7 and SSBP/I.